Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.182
0.00 (-0.17%)
Apr 25, 2024, 4:00 PM EDT - Market closed

MTNB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
1.13.190.030000000
Upgrade
Revenue Growth (YoY)
-65.62%9560.61%--------
Upgrade
Gross Profit
1.13.190.030000000
Upgrade
Selling, General & Admin
10.3711.110.1910.017.787.987.644.314.815.29
Upgrade
Research & Development
14.4916.6814.5814.3611.236.799.013.955.295.18
Upgrade
Operating Expenses
24.8627.7824.7724.3619.0114.7716.658.2610.1110.46
Upgrade
Operating Income
-23.77-24.59-24.74-24.36-19.01-14.77-16.65-8.26-10.11-10.46
Upgrade
Other Expense / Income
-0.82-3.59-1.45-1.92-1.64-0.18-0.81-0.66-0.97-0.24
Upgrade
Pretax Income
-22.94-21-23.28-22.45-17.37-14.59-15.84-7.6-9.14-10.22
Upgrade
Income Tax
00000-0.51-0.36000
Upgrade
Net Income
-22.94-21-23.28-22.45-17.37-14.08-15.49-7.6-9.14-10.22
Upgrade
Preferred Dividends
000.40.790.920.9117.354.3900
Upgrade
Net Income Common
-22.94-21-23.68-23.24-18.3-14.99-32.84-11.99-9.14-10.22
Upgrade
Shares Outstanding (Basic)
2172172101971459890585132
Upgrade
Shares Outstanding (Diluted)
2172172101971459890585132
Upgrade
Shares Change
0.21%3.16%6.75%35.61%48.00%8.43%56.93%11.99%60.49%68.81%
Upgrade
EPS (Basic)
-0.11-0.10-0.11-0.12-0.13-0.15-0.36-0.21-0.18-0.32
Upgrade
EPS (Diluted)
-0.11-0.10-0.11-0.12-0.13-0.15-0.36-0.21-0.18-0.32
Upgrade
Free Cash Flow
-15.5-20.05-15.48-17.37-14.5-10.86-12.4-6.12-7.89-8.25
Upgrade
Free Cash Flow Per Share
-0.07-0.09-0.07-0.09-0.10-0.11-0.14-0.11-0.15-0.26
Upgrade
Gross Margin
100.00%100.00%100.00%-------
Upgrade
Operating Margin
-2168.43%-771.33%-74954.55%-------
Upgrade
Profit Margin
-2093.25%-658.63%-71754.55%-------
Upgrade
Free Cash Flow Margin
-1413.87%-628.86%-46918.18%-------
Upgrade
EBITDA
-22-20.1-22.5-21.67-16.59-14.37-15.74-7.55-9.09-10.18
Upgrade
EBITDA Margin
-2007.39%-630.46%-68187.88%-------
Upgrade
Depreciation & Amortization
0.940.90.780.770.780.220.10.050.040.04
Upgrade
EBIT
-22.94-21-23.28-22.45-17.37-14.59-15.84-7.6-9.14-10.22
Upgrade
EBIT Margin
-2093.25%-658.63%-70554.55%-------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).